# 18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer

> **NCT02809690** · PHASE1 · TERMINATED · sponsor: **University of Southern California** · enrollment: 18 (actual)

## Conditions studied

- Prostate Neoplasm

## Interventions

- **DEVICE:** CAT
- **DRUG:** 18F-FMAU
- **OTHER:** Laboratory Biomarker Analysis
- **PROCEDURE:** Multiparametric Magnetic Resonance Imaging
- **DEVICE:** Positron Emission Tomography
- **DEVICE:** Ultrasound

## Key facts

- **NCT ID:** NCT02809690
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09-12
- **Primary completion:** 2021-07-21
- **Final completion:** 2021-07-21
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2023-09-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02809690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02809690, "18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02809690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*